Abstract
Lumbar disc herniation (LDH) is a common cause for low back pain. In this study, we aimed to explore the effects of a specific Lactobacillus paracasei (L. paracasei), L. paracasei S16, on the symptoms of LDH using a mouse model of LDH. The results showed that L. paracasei S16 treatment improved the behavior, increased the cell proliferation, and decreased the apoptosis in LDH mice. Moreover, L. paracasei S16 treatment alleviated the aberrant inflammation response in the LDH mice, which is characterized by the decreased anti-inflammatory cytokines, increased pro-inflammatory cytokines, and decreased percentage of Th1 and Th2 cells and Th17/Treg ratio. 16S rRNA sequencing results showed that the LDH mice treated with L. paracasei S16 have higher relative abundance of Lachnospiraceae and Ruminococcaceae and lower abundance of Lactobacillaceae than mice in the LDH group. Additionally, the serum metabolites involved in the linoleic acid metabolism, alanine. aspartate, and glutamate, glycerophospholipid, and TCA cycle were significantly decreased and the metabolite involved in purine metabolism was significantly increased after the L. paracasei S16 treatment in the LDH mice. These results showed that administration of L. paracasei S16 can improve inflammation response, alter gut microbiota, and modulate serum metabolomics in a mouse model of LDH.
Highlights
Recent studies have shown that the Lactobacillus paracasei (L. paracasei) treatment can alleviate inflammation-related disorders by modulating the production of anti- and pro-inflammatory cytokines [9, 10]
The mechanical withdrawal at the postoperation day (POD) 3, 14, and 28 and thermal withdraw from the POD 3 to 28 were significantly higher in the Lumbar disc herniation (LDH) + Probiotic group than the LDH group (P < 0.05) (Figures 1A,B), suggesting that L. paracasei S16 treatment significantly alleviated the behavior of LDH mice
We investigated the effects of L. paracasei S16 administration on the symptoms of LDH in a mouse model
Summary
Recent studies have shown that the Lactobacillus paracasei (L. paracasei) treatment can alleviate inflammation-related disorders by modulating the production of anti- and pro-inflammatory cytokines [9, 10]. Whether the L. paracasei can alleviate aberrant inflammation in LDH mice by modulating the gut microbiota is unclear. We investigated whether L. paracasei exert antiinflammatory effects via modulating T cell function and gut microbiota in the mice with LDH. To test this hypothesis, we examined the effects of specific strain of L. paracasei, L. paracasei S16, on the behavior and the production of inflammatory cytokines in LDH mice. We analyzed the gut microbiota and serum metabolomics to further explored the mechanism
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
